Thanks to DSF Charitable Foundation…

Researchers at Carnegie Mellon’s Center for Nucleic Acids Science and Technology (CNAST) are advancing their work aimed at better understanding and treating disease.

The DSF Charitable Foundation gave a $3.9 million grant to further the development of novel biomedical tools targeted at monitoring and manipulating gene expression.

Simply put, DNA contains instructions for making proteins. RNA then uses those instructions to make functional proteins. That process is known as gene expression.

But if something goes awry during the gene expression process, too much or too little protein can be made. At times, this can have devastating results – even increasing the risk of certain types of cancer for some.

“At CNAST we are creating tools that will help us to answer fundamental scientific questions and lead to the development of practical applications for treating genetic and infectious diseases,” said John Woolford, professor of biological sciences.

Bruce Armitage, professor of chemistry, is also co-director of CNAST. CNAST is comprised of an interdisciplinary team of researchers from Carnegie Mellon’s chemistry and biological sciences departments.

Find out more >>

No comments: